Description: Chronic Myeloid Leukemia, which is commonly known as CML, is a serious blood condition where the body produces an uncontrollable number of abnormal blood cells. Fortunately, modern treatment options exist to treat this disorder. Chief among these treatments is an oral medication which acts as a Tyrosine Kinase Inhibitor. TKI can block certain blood cells which causes them to die, thus allowing the patient an effective treatment option with minimal side effects or lifestyle changes. For additional information about Chronic Myeloid Leukemia, visit the MyCMLCare website.